CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-10 | LEUNG SANDRA EVP, General Counsel | Shares withheld for taxes | −11,695 | $53.79 | $629K | 347,385.33 |
| 2024-03-10 | LEUNG SANDRA EVP, General Counsel | Option exercise · Market Share Units | −5,789 | 0 | ||
| 2024-03-10 | LEUNG SANDRA EVP, General Counsel | Option exercise · Market Share Units | −5,856 | 5,858 | ||
| 2024-03-10 | LEUNG SANDRA EVP, General Counsel | Other disposition · Market Share Units | −5,349 | 10,700 | ||
| 2024-03-10 | LEUNG SANDRA EVP, General Counsel | Other disposition · Market Share Units | −5,415 | 16,248 | ||
| 2024-03-10 | LEUNG SANDRA EVP, General Counsel | Grant or award · Market Share Units | +28,638 | 28,638 | ||
| 2024-03-10 | LEUNG SANDRA EVP, General Counsel | Option exercise · Performance Shares | −35,139 | 0 | ||
| 2024-03-10 | LEUNG SANDRA EVP, General Counsel | Grant or award · Performance Shares | +42,957 | 42,957 | ||
| 2024-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise | +994 | 7,920 | ||
| 2024-03-10 | Plenge Robert M EVP, Chief Research Officer | Other disposition | −157 | 7,763 | ||
| 2024-03-10 | Plenge Robert M EVP, Chief Research Officer | Shares withheld for taxes | −246 | $53.79 | $13K | 7,517 |
| 2024-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise | +1,164 | 8,681 | ||
| 2024-03-10 | Plenge Robert M EVP, Chief Research Officer | Other disposition | −201 | 8,480 | ||
| 2024-03-10 | Plenge Robert M EVP, Chief Research Officer | Shares withheld for taxes | −283 | $53.79 | $15K | 8,197 |
| 2024-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise | +6,985 | 15,182 | ||
| 2024-03-10 | Plenge Robert M EVP, Chief Research Officer | Other disposition | −2,431 | 12,751 | ||
| 2024-03-10 | Plenge Robert M EVP, Chief Research Officer | Shares withheld for taxes | −1,436 | $53.79 | $77K | 11,315 |
| 2024-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise · Market Share Units | −994 | 0 | ||
| 2024-03-10 | Plenge Robert M EVP, Chief Research Officer | Option exercise · Market Share Units | −1,164 | 1,165 | ||
| 2024-03-10 | Plenge Robert M EVP, Chief Research Officer | Other disposition · Market Share Units | −1,107 | 2,214 |
Page 31 of 40 · 799 trades